BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6401506)

  • 1. Clinical aspects of delta infection.
    Moestrup T; Hansson BG; Widell A; Nordenfelt E
    Br Med J (Clin Res Ed); 1983 Jan; 286(6359):87-90. PubMed ID: 6401506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with delta agent in Sweden: introduction of a new hepatitis agent.
    Hansson BG; Moestrup T; Widell A; Nordenfelt E
    J Infect Dis; 1982 Oct; 146(4):472-8. PubMed ID: 7119477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
    Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
    Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
    Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
    Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The delta agent in acute and chronic hepatitis B infection in Sweden.
    Norkrans G; Hermodsson S; Iwarson S
    Scand J Gastroenterol; 1983 Jul; 18(5):675-8. PubMed ID: 6675189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
    Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
    J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant B viral hepatitis: role of delta agent.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of delta infection on severity of hepatitis B.
    Smedile A; Farci P; Verme G; Caredda F; Cargnel A; Caporaso N; Dentico P; Trepo C; Opolon P; Gimson A; Vergani D; Williams R; Rizzetto M
    Lancet; 1982 Oct; 2(8305):945-7. PubMed ID: 6127458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta agent infection in Melbourne.
    Hoy JF; Hansson BG; Dimitrakakis M; Gust I; Lucas CR
    J Med Virol; 1984; 13(4):339-45. PubMed ID: 6736942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant delta hepatitis in chronic asymptomatic HBsAg carriers.
    Tassopoulos N; Roumeliotou-Karayannis A; Nakopoulou L; Calafatas P; Papaevangelou G
    JAMA; 1985 Apr; 253(16):2362-3. PubMed ID: 3981762
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute delta hepatitis without circulating HBsAg.
    De Cock KM; Govindarajan S; Redeker AG
    Gut; 1985 Feb; 26(2):212-4. PubMed ID: 3967840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier.
    Bonino F; Hoyer B; Ford E; Shih JW; Purcell RH; Gerin JL
    Hepatology; 1981; 1(2):127-31. PubMed ID: 6169614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant delta hepatitis in chronic hepatitis B infection.
    De Cock KM; Govindarajan S; Redeker AG
    JAMA; 1984 Nov; 252(19):2746-8. PubMed ID: 6387205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
    Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
    Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of delta infection in drug addicts in Valencia, Spain.
    Rodrigo JM; Serra MA; Gimeno V; Olmo JA; Aparisi L; Escudero A; Wassel AH; Bixquert M
    Prog Clin Biol Res; 1987; 234():407-8. PubMed ID: 3628399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.